Özbek İpteç Betül, Balik Ahmet Rıfat, Yüksel Selcen, Yilmaz Fatma Meriç, Yilmaz Gülsen
Ankara Yıldırım Beyazıt University, Department of Medical Biochemistry, Ankara, Turkey.
Ankara Yıldırım Beyazıt University, Department of Medical Biochemistry, Ankara, Turkey.
Clin Biochem. 2018 Nov;61:28-33. doi: 10.1016/j.clinbiochem.2018.08.009. Epub 2018 Aug 25.
Low-density lipoprotein cholesterol (LDL) is an important risk factor for cardiovascular disease (CVD) and generally measured after 8-12 h fasting. However, some recent studies have pointed that non-fasting lipoproteins, especially LDL concentrations, are better indicators for demonstrating CVD risk and atherosclerosis. They asserted that nutrition is a negligible factor on changes in lipoprotein concentrations and claimed this difference as a result of hemodilution effect, caused from fluid intake and can be eliminated by applying some adjustments. We aimed to compare the fasting and non-fasting LDL values of the same individuals and discuss whether non-fasting and fasting LDL results can be used in place of each other, directly or after applying hemodilution correction models.
Fasting and non-fasting blood samples of 248 apparently healthy participants were collected. Lipid panel tests, albumin and hemoglobin levels were studied in each sample. Results were evaluated in seven different models which were recommended to correct the hemodilution effect on fasting and non-fasting lipid concentrations of the same individual. Concordance of fasting and non-fasting risk group of the individual were calculated according to the National Cholesterol Education Program classification.
Fasting and non-fasting LDL and non-high density lipoprotein cholesterol (non-HDL) concentrations were significantly different in every model (p < 0.001). Concordance results of fasting and non-fasting LDL and non-HDL risk groups were 63.8% and 77.9% respectively.
Our results demonstrated that fasting and non-fasting LDL and non-HDL concentrations could not be used in place of each other even when the results were adjusted for elimination of the hemodilution effect.
低密度脂蛋白胆固醇(LDL)是心血管疾病(CVD)的一个重要风险因素,通常在禁食8 - 12小时后测量。然而,最近一些研究指出,非空腹脂蛋白,尤其是LDL浓度,是显示CVD风险和动脉粥样硬化的更好指标。他们断言,营养对脂蛋白浓度变化的影响可忽略不计,并声称这种差异是由液体摄入引起的血液稀释效应导致的,通过一些调整可以消除这种差异。我们旨在比较同一人群的空腹和非空腹LDL值,并讨论非空腹和空腹LDL结果是否可以直接相互替代,或者在应用血液稀释校正模型后相互替代。
收集了248名表面健康参与者的空腹和非空腹血液样本。对每个样本进行血脂检测、白蛋白和血红蛋白水平检测。结果在七种不同模型中进行评估,这些模型被推荐用于校正同一人空腹和非空腹血脂浓度的血液稀释效应。根据国家胆固醇教育计划分类计算个体空腹和非空腹风险组的一致性。
在每个模型中,空腹和非空腹LDL以及非高密度脂蛋白胆固醇(非HDL)浓度均存在显著差异(p < 0.001)。空腹和非空腹LDL及非HDL风险组的一致性结果分别为63.8%和77.9%。
我们的结果表明,即使对结果进行调整以消除血液稀释效应,空腹和非空腹LDL及非HDL浓度也不能相互替代。